FDA Adverse Event Injury Summary report: N

OT ULTRAMINI METER

MDR report key: 3873450 · Received June 14, 2014

Report

Report Number
2939301-2014-14428
Event Type
Injury
Date Received
June 14, 2014
Report Date
June 6, 2014
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K061118
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2014, THE LAY-USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT THE ONETOUCH ULTRAMINI METER IS GIVING AN ERROR 4 ISSUE AND A ¿CR 4¿ MESSAGE. THIS COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. ACCORDING TO THE PATIENT, SHE HAD SOME EYE SIGHT ISSUE PRIOR TO THE ONSET OF THE ERROR 4 ISSUE AND ¿CR 4¿ MESSAGE. ON THE DAY THE REPORT ISSUE BEGAN, THE PATIENT REPORTEDLY WENT FOR A DOCTOR¿S OFFICE VISIT. SHE REPORTEDLY RECEIVED HCP TREATMENT WITH INSULIN TREATMENT (20 UNITS OF APIDRIA EVERY HOUR FOR 6 HOURS). THE PATIENT¿S MEDICATION OF APIDRA AND SOLOSTAR WAS INCREASED TO MANAGE HER DIABETES THAT DAY. IT WOULD HAVE BEEN HELPFUL TO OBTAIN MORE INFORMATION SURROUNDING THE ALLEGED REQUIRED HCP TREATMENT; HOWEVER, THE PATIENT WAS NOT AVAILABLE FOR FOLLOW-UP INFORMATION. THE ERROR 4 ISSUE AND ¿CR 4¿ MESSAGE WAS NOT RESOLVED WITH TRAINING. THE TEST STRIPS WERE WITHIN THE DISCARD DATE. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REQUIRED INSULIN TREATMENT SUGGESTIVE FOR HYPERGLYCEMIA. THE LFS PRODUCTS WERE REPLACED AND REQUESTED BACK FOR INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
351784 OT ULTRAMINI METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3545265

Patients

Seq Age Sex Outcome Treatment
1 40 YR Required Intervention